The expression of intronic miRNAs, miR-483 and miR-483*, and their host gene, Igf2, in murine osteoarthritis cartilage

International Journal of Biological Macromolecules

Volumn 61, Issue , 2013, Pages 43-49

  Qi, Yuebin ^a   Ma, Ning ^b   Yan, Feng ^a   Yu, Zhange ^a   Wu, Guodong ^b   Qiao, Yu ^b   Han, Dong ^b   Xiang, Ying ^b   Li, Fuyuan ^b   Wang, Wenbo ^a   Gao, Xu ^b  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Cartilage; IGF2; MicroRNA; MiR 483; Osteoarthritis

Indexed keywords

ADAMTS1 PROTEIN; COLLAGENASE 3; COMPLEMENTARY DNA; INTERLEUKIN 1BETA; MICRORNA; MICRORNA 483; OSTEOGENIC PROTEIN 1; SOMATOMEDIN B; TRANSCRIPTION FACTOR SOX5; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARTILAGE; CARTILAGE DEGENERATION; CONTROLLED STUDY; CYTOKINE RELEASE; GENE; HISTOPATHOLOGY; IGF2 GENE; IMMUNOHISTOCHEMISTRY; INTRON; MALE; MOUSE; NONHUMAN; OSTEOARTHRITIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA SYNTHESIS; UPREGULATION;

EID: 84880684250     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2013.06.006     Document Type: Article

References (34)

1. Hamel M.B., Toth M., Legedza A., et al. Joint replacement surgery in elderly patients with severe osteoarthritis of the hip or knee: decision making, postoperative recovery, and clinical outcomes. Arch Intern Med 2008, 168(13):1430-1440.
2. Goldring M.B., Goldring S.R. Osteoarthritis. J Cell Physiol 2007, 213(3):626-634.
3. Martinek V. Anatomy and pathophysiology of articular cartilage. Dtsche Z Sportmed 2003, 54(6):166-170.
4. Umlauf D., Frank S., Pap T., et al. Cartilage biology, pathology, and repair. Cell Mol Life Sci 2010, 67:4197-4211.
5. Qiao Y., Ma N., Wang X., et al. MiR-483-5p controls angiogenesis in vitro and targets serum response factor. FEBS Lett 2011, 585(19):3095-3100.
6. Yamasaki K., Nakasa T., Miyaki S., et al. Expression of microRNA-146a in osteoarthritis cartilage. Arthritis Rheum 2009, 60(4):1035-1041.
7. Stanczyk J., Ospelt C., Karouzakis E., et al. Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation. Arthritis Rheum 2011, 63(2):373-381.
8. Miyaki S., Sato T., Inoue A., et al. MicroRNA-140 plays dual roles in both cartilage development and homeostasis. Genes Dev 2010, 24:1173-1185.
9. Araldi E., Schipani E. MicroRNA-140 and the silencing of osteoarthritis. Genes Dev 2010, 24:1075-1080.
10. Miyaki S., Nakasa T., Otsuki S., et al. MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses. Arthritis Rheum 2009, 60(9):2723-2730.
11. Iliopoulos D., Malizos K.N., Oikonomou P., et al. Integrative microRNA and proteomic approaches identify novel osteoarthritis genes and their collaborative metabolic and inflammatory networks. PLoS ONE 2008, 3(11):1-10.
12. Steck E., Boeuf S., Gabler J., et al. Regulation of H19 and its encoded microRNA-675 in osteoarthritis and under anabolic and catabolic in vitro conditions. J Mol Med 2012.
13. Cui H. Loss of imprinting of IGF2 as an epigenetic marker for the risk of human cancer. Dis Markers 2007, 1(2):105-112.
14. Chao W., D'Amore P.A. IGF2: epigenetic regulation and role in development and disease. Cytokine Growth Factor Rev 2008, 19:111-120.
15. Della Vittoria Scarpati G., Falcetta F., Carlomagno C., et al. A specific miRNA signature correlates with complete pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2011, 12.
16. Patterson E., Webb R., Weisbrod A., et al. The microRNA expression changes associated with malignancy and SDHB mutation in pheochromocytoma. Endocr Relat Cancer 2012, 1.
17. ao H.J., Zhang S., Zhou Y., et al. MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer. FEBS Lett 2011, 585(1):207-213.
18. Ma N., Wang X., Qiao Y., et al. Coexpression of an intronic microRNA and its host gene reveals a potential role for miR-483-5p as an IGF2 partner. Mol Cell Endocrinol 2010, 11.
19. Janusz M.J., Bendele A.M., Brown K.K., et al. Induction of osteoarthritis in the rat by surgical tear the meniscus: inhibition of joint damage by a matrix metalloproteinase inhibitor. Osteoarthritis Cart 2002, 10:785-791.
20. Xiaoqiang E., Cao Y., Meng H., et al. Dendritic cells of synovium in experimental model of osteoarthritis of rabbits. Cell Physiol Biochem 2012, 30(1):23-32.
21. Michihisa Zemmyo E., Meharra J., Kühn K., et al. Accelerated, aging-dependent development of osteoarthritis in α1 integrin-deficient mice. Arthritis Rheum 2003, 48(10):2873-2880.
22. Sommerlath K.G., Gillquist J. The effect of anterior cruciate ligament resection and immediate or delayed implantation of a meniscus prosthesis on knee joint biomechanics and cartilage: an experimental study in rabbits. Clin Orthop Relat Res 1993, 267-275.
23. Witkos T.M., Koscianska E., Krzyzosiak W.J. Practical aspects of microRNA target prediction. Curr Mol Med 2011, 11(2):93-109.
24. Akhtar N., Rasheed Z., Sangeetha R., et al. MicroRNA-27b regulates the expression of matrix metalloproteinase 13 in human osteoarthritis chondrocytes. Arthritis Rheum 2010, 62(5):1361-1371.
25. Schwarz D.S., Hutvagner G., Du T., et al. Asymmetry in the assembly of the RNAi enzyme complex. Cell 2003, 115(2):199-208.
26. Shin C. Cleavage of the star strand facilitates assembly of some microRNAs into Ago2-containing silencing complexes in mammals. Mol Cells 2008, 26(3):308-313.
27. Zhou H., Huang X., Cui H., et al. miR-155 and its star-form partner miR-155* cooperatively regulate type I interferon production by human plasmacytoid dendritic cells. Blood 2010, 116(26):5885-5894.
28. Bertero T., Gastaldi C., Bourget-Ponzio I., et al. miR-483-3p controls proliferation in wounded epithelial cells. FASEB J 2011, 3092-3015.
29. Bhaumick B., Bala R.M. Differential effects of insulin-like growth factors I and II on growth, differentiation and glucoregulation in differentiating chondrocyte cells in culture. Acta Endocrinol 1991, 125:201-211.
30. Clokie S.J.H., Lau P., Kim H.H., et al. MicroRNAs in the pineal gland. miR-483 regulates melatonin synthesis by targeting arylalkylamine N-acetyltransferase. J Biol Chem 2012, 287(30):25312-25324.
31. Veronese A., Lupini L., Consiqlio J., et al. Oncogenic role of miRNA-483-3P at the IGF2/483 locus. Cancer Res 2010, 70(8):3140-3149.
32. Wang L., Shi M., Hou S., et al. miR-483-5P suppresses the proliferation of glioma cells via directly targeting ERK1. FEBS Lett 2012, 586(9):1312-1317.
33. Babar I.A., Cheng C.J., Booth C.J., et al. Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma. Proc Natl Acad Sci U S A 2012, 6.
34. Taqliaferri P., Rossi M., Di Martino M.T., et al. Promises and challenges of microRNA-based treatment of multiple myeloma. Curr Cancer Drug Targets 2012, 6.